imatinib
Interviews and expert commentary tagged “imatinib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology in Advance – March 15th, 2008
Volume 16 Number 6 (March 15th, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) American Society of Hematology Annual Meeting (December 8-11, 2007
Live Report from ASH:<br />Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML
Richard Stone RICHARD STONE, Dana-Farber Cancer Institute, Boston GEORGE CANELLOS, Dana-Farber Cancer Institute New data shows that dasatinib is giving durable responses in patients with chronic phase
Dec. 15, 2006: Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006
Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Respo
ASCO Audio Journal of Oncology – September 1st, 2006
Mark Socinski Bruce Johnson Neil Shah Doug Smith Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer REFERENCE: Abstract 7001 Mark A. Socinski, Univerisity of North Carolina